IP Library Granted Patent US 7,785,843
Granted Patent B2
US 7,785,843 · App. 10/874,898 · Granted Aug 31, 2010

Target-specific compomers and methods of use

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,785,843
App. No.
10/874,898
Granted
Aug 31, 2010
Kind
B2
Abstract

Provided herein are libraries of nucleic acid species each comprising a transcription unit having a promoter region operatively linked to a coding sequence. The coding sequence of each nucleic acid species encodes a RNA cleavage substrate comprising a unique compomer species and a cleavage site. Each compomer species has a molecular mass distinguishable from the molecular mass of other compomer species in the library, and cleavage at a cleavage site releases a polynucleotide comprising the compomer species from the RNA cleavage substrate.

Claims (15)

1. A library comprising two or more nucleic acid species, wherein:

each nucleic acid species comprises a transcription unit comprising a promoter region operatively linked to a coding sequence;

the coding sequence of each nucleic acid species encodes a RNA consisting of (i) a unique compomer species, and (ii) a terminal nucleotide sequence;

each compomer species has a molecular mass distinguishable from the molecular mass of other compomer species in the library;

each of the unique compomer species in the library consists of only one, two or three nucleotide types; and

the terminal nucleotide sequence consists of one or more nucleotide types not included in the unique compomer species of the RNA.

2. The library of claim 1 , wherein the nucleic acid species is selected from the group consisting of a source of genetic variation among members of the same species and a chemically modified nucleic acid molecule.

3. The library of claim 1 , wherein the nucleotides in the compomer and terminal nucleotide sequence are selected from the group consisting of adenine (A), thymine (T), guanine (G), and cytosine (C).

4. The library of claim 1 , wherein the promoter region is selected from the group consisting of a bacterial, a bacteriophage, a consensus, a viral and a eukaryotic promoter region.

5. The library of claim 1 , wherein the promoter region is a bacteriophage promoter region selected from the group consisting of a T7, an SP6, and a T3 promoter region.

6. The library of claim 1 , wherein each nucleic acid species comprises a cleavage site that releases the compomer.

7. The library of claim 6 , wherein the cleavage site is located after the compomer.

8. The library of claim 1 , wherein the terminal sequence is one nucleotide.

9. The library of claim 1 , wherein there are twenty (20) or more nucleic acid species spaced substantially evenly across a mass range.

10. The library of claim 9 , wherein the mass range is between about 2500 Daltons and about 10000 Daltons.

Assignments (7)
SECURITY INTEREST Recorded Dec 10, 2021
From: AGENA BIOSCIENCE, INC.
To: JPMORGAN CHASE BANK, N.A.
Reel/Frame 058358/0661 →
RELEASE OF SECURITY INTEREST Recorded Dec 7, 2021
From: MIDCAP FUNDING IV TRUST
To: AGENA BIOSCIENCE, INC.
Reel/Frame 058741/0005 →
RELEASE OF SECURITY INTEREST IN REEL 041621 FRAME 0548 Recorded Jul 13, 2021
From: MIDCAP FINANCIAL TRUST
To: AGENA BIOSCIENCE, INC.
Reel/Frame 056860/0557 →
SECURITY INTEREST Recorded Mar 21, 2017
From: AGENA BIOSCIENCE, INC.
To: MIDCAP FINANCIAL TRUST, AS AGENT
Reel/Frame 042050/0888 →
SECURITY INTEREST Recorded Feb 3, 2017
From: AGENA BIOSCIENCE, INC.
To: MIDCAP FINANCIAL TRUST
Reel/Frame 041621/0548 →
CHANGE OF NAME Recorded Jun 27, 2014
From: BIOSCIENCES ACQUISITION COMPANY
To: AGENA BIOSCIENCE, INC.
Reel/Frame 033248/0073 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 16, 2014
From: SEQUENOM, INC.
To: BIOSCIENCES ACQUISITION COMPANY
Reel/Frame 033182/0062 →